// App-Quantinova.ai

: Late Breaking Abstract - A connected inhaler system improves adherence to fluticasone furoate/vilanterol in asthma

Researchers

Presenter

  • Alison Moore

Principal Investigators

  • Andrew Preece

  • Raj Sharma

  • Liam G Heaney

  • Richard W Costello

  • Robert Wise

  • Andrea Ludwig-Sengpiel

  • Giselle Mosnaim

  • Jamie Rees

  • Ryan Tomlinson

  • Ruth Tal-Singer

  • Neil Barnes

Medical Centers

  • GlaxoSmithKline, Stockley Park, United Kingdom

  • GlaxoSmithKline Plc, Brentford, United Kingdom

  • Queens University, Belfast, Northern Ireland, UK

  • RCSI, Dublin, Ireland

  • The Johns Hopkins University, Baltimore, United States of America

  • KLB Gesundheitsforschung Luebeck, Luebeck, Germany,

  • NorthShore University Health System, Evanston, Illinois, United States

  • GlaxoSmithKline plc., Upper Providence, Collegeville, Pennsylvania, United States of America

  • GlaxoSmithKline plc.; St Bartholomew’s Hospital, Brentford; London, United Kingdom

Locations

  • United Kingdom

  • Ireland

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Alpha-1-microglobulin/bikunin precursor

Drug/Treatment

  • Fluticasone furoate

  • Salbutamol

Outcome

  • N/A

Study Design

  • Randomized

  • Fixed Dose

  • Open Label

  • Multicenteric

  • Parallel Group

Phase

  • NA

Study Id's

  • NCT033800429

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved